Suggestions
Greg Parekh
Managing Partner New Rhein Healthcare Investors
Professional Background
Greg Parekh is an accomplished founder and investor known for his extensive experience in the pharmaceutical industry and investment banking. With a specialization in pharmaceuticals, biotechnology, medical devices, oncology, and big data, Greg has built a remarkable career characterized by leadership and strategic foresight. His impact is especially notable in both global business development and general management, demonstrating his capability to drive innovation and growth across diverse sectors.
During his tenure as Chairman of the Board at Alveus Therapeutics and as a member of the Board of Directors at American Injectables, Greg showcased his exceptional leadership skills, guiding these organizations through critical growth phases. His role as Chairman of the Board of Directors at Butterfly Medical and as a founder and Managing Partner at New Rhein Healthcare Investors further established him as a prominent figure in healthcare investment. In these positions, Greg played a key role in fostering partnerships, securing investments, and paving the way for new innovations in medical technology and pharmaceuticals.
His executive leadership experience also includes serving as the Chief Executive Officer at Biocartis, where he was instrumental in driving the company's strategic vision and operational excellence. Additionally, his experience as a non-executive board member at NOVAGALI PHARMA SA highlights his ability to offer valuable insights and guidance to companies navigating complex market landscapes.
Education and Achievements
Greg Parekh's academic background is deeply rooted in economics, underscoring his analytical and strategic approach to problem-solving. He earned his PhD in Economics from the prestigious Northwestern University - Kellogg School of Management. This rigorous educational experience equipped him with a strong foundation in economic theory and practice, which he has successfully applied throughout his career to influence business decision-making and policy development.
Prior to his PhD, Greg also earned a BA in Economics and Political Science from the University of Rochester. This broad educational background not only honed his understanding of economic systems but also enriched his perspective on political and regulatory environments affecting the healthcare industry.
Notable Achievements
Throughout his career, Greg has made numerous contributions to the fields of healthcare and investment. His involvement as a member of the CancerLinQ Board of Governors at ASCO's CancerLinQ® signifies his commitment to improving oncology data access and usage, ultimately enhancing patient outcomes.
As the former Head of M+A at Novartis, Greg was at the forefront of major mergers and acquisitions, utilizing his keen strategic insights to facilitate impactful deals that advanced the company’s market position. His success at Deutsche Bank as a Managing Director and at Bear Stearns as a Vice President further illustrate his extensive banking expertise, particularly in managing high-stakes financial transactions and fostering investor relationships.
Greg Parekh’s career has been marked by a dedication to excellence, innovation, and transformative leadership. His multifaceted experience across high-level positions in investment banking and the pharmaceutical industry positions him as an influential thought leader and a sought-after partner in healthcare investments and strategic business development.
